Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -8.93% |
| 2024 | -40.01% |
| 2023 | 0.28% |
| 2022 | 25.22% |
| 2021 | 79.68% |
| 2020 | 61.44% |
| 2019 | 8.50% |
| 2018 | 0.71% |
| 2017 | 99.51% |
| 2016 | 101.37% |